High bilirubin levels increase the risk of developing bilirubin gallstones—a type of gallstone more prevalent in Sickle Cell ...

Gallbladder disease refers to any medical condition that affects your gallbladder, a small organ under your liver that stores bile. The most common symptoms of gallbladder disease are abdominal pain, ...

Biliary tract disease describes any disease that affects the biliary tract the gall bladder, bile ducts and accompanying structures. Examples include primary sclerosing cholangitis, secondary ...

However, assessment of their efficacy is limited by the inadequacies of current methods of dyskinesia measurement. The objective was to develop and validate a portable device capable of objectively ...

Significantly increased risk for tardive dyskinesia seen with doses >75 mg/day at last prescription and as maximum dose. HealthDay News — Antipsychotics at doses >75 mg/day are associated with ...

A review article by veterinary specialist and associate professor at Utrecht University Paul Mandigers and colleagues brings together knowledge on the movement disorder paroxysmal dyskinesia (PD), ...

KETAMINE shows promise in managing levodopa-induced dyskinesia by disrupting abnormal brain activity and promoting lasting neuroplasticity, new research has shown. Levodopa-induced dyskinesia is a ...

Service specifications are important in clearly defining the standards of care expected from organisations funded by NHS England to provide specialised care. The specifications have been developed by ...

Beyond the more recognized cause of bacterial and viral infections and primary immunodeficiencies, other genetic conditions such as cystic fibrosis and primary ciliary dyskinesia (PCD) can also ...

Livdelzi (seladelpar) is a medicine that can treat primary biliary cholangitis (PBC) by reducing the amount of bile in your body. It does this by signaling the body to stop making bile acid.